Healthcare Marketing Communications and PR Agency
7th August 2015
Our aim was to increase the availability of the drug in UK and European clinical institutions by working with influential oncology nurses to identify each individual market’s training [...]
Newcells Biotech wanted to strengthen their position in the human induced pluripotent stem cell (hiPSC) market and increase the number of unqualified leads to a broader mix of global [...]
As a healthcare marketing communications and PR agency based in the North East, getting social is second nature to Onyx Health.
We believe that social media services are [...]
The content we have created for UL Medicines has taken them from being a start-up to now being viewed as an industry leader and expert in the unlicensed medicines market.
Newcells Biotech wanted to strengthen their position in the human induced pluripotent stem cell (hiPSC) market and increase the number of unqualified leads to a broader mix of companies in a [...]
14th July 2015
Our client had hit a barrier and sales had stagnated. Early adopters had bought the product, but the sales team were reporting that they could not convince hospital Trusts to purchase the [...]
Our client wanted to continue to grow their share of the vertigo market but no longer provided sales force support for the product.
Our aim was to develop a range of [...]
UL Medicines was a relative newcomer to the unlicensed market. Through personal contacts in hospital pharmacy they had been able to establish a revenue stream but now needed to grow this to [...]
+44(0)191 640 3638
Onyx Health Limited, Maling Exchange, Hoults Yard, Walker Road, Newcastle-Upon-Tyne, NE6 1AB
© Onyx Health 2019